Published in Women's Health Weekly, November 20th, 2003
The Panbio test for West Nile virus was introduced earlier this year in response to the rapid spread of the disease in North America (which in more severe cases can cause encephalitis or meningitis). Panbio's test is currently the only product on the market with U.S. Food and Drug Administration (FDA) clearance for the diagnosis of the disease in humans.
Also important in this alliance will be Panbio's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.